Global Markets
Home›Global Markets›Asia›Asia sees surge in healthcare private deals for surgic…
Asia sees surge in healthcare private deals for surgical robotics, BCI
Healthcare private equity funds in Asia-Pacific deals nearly doubled to 129 in the first half of the year, according to Bain & Company data.
Private investors across Asia, including family offices based in Hong Kong, are increasing bets on advanced healthcare technologies such as brain-computer interfaces and surgical robotics, as deal activity picks up in the region amid China’s biotechnology boom, according to SCMP Economy. Raffles Family Office, which manages about US$2 billion in assets, says these themes are appearing more frequently than they did a couple of years ago. Deputy group CEO William Chow attributed the demand to demographic trends, saying Asia’s aging population creates long term need for better surgery and medicine.
Bain & Company data cited by SCMP Economy showed the number of healthcare private equity funds involved in Asia-Pacific deals nearly doubled to 129 in the first half of the year, up from 66 a year earlier. Globally, the healthcare private equity sector recorded 184 buyout deals over the same period, while total disclosed deal value fell 18.0 percent year on year to US$51 billion.
SCMP Economy also highlighted a shift in how artificial intelligence is being used, with AI adoption moving from drug discovery into clinical applications to support hospital surgery workflows. In remarks during a panel discussion, Raffles Family Office also described AI uses such as real time sensor inputs in surgical tools and feedback to help clinicians adjust decisions.